Decision Resources

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Monday, March 30, 2015

Having accurate customer reference data for all healthcare professionals, healthcare organizations and affili­ations across life sciences’ major markets—and managing it all—is a burden Veeva Systems has addressed with the launch of a new streamlined approach to deliver cus­tomer data sourced locally and consolidated into a single global reference database.

[Read More]

Report: Type 2 diabetes population to expand in China

Wednesday, December 10, 2014

For the treatment of type 2 diabetes in China, patient access to premium-priced agents is impeded as not all patients can afford these drugs, Burlington, Mass.-based Decision Resources Group has found. The National Reimbursement Drug List was last updated in 2009, and several antidiabetic drug classes (e.g. DPP-IV inhibitors and GLP-1 receptor agonist) are not covered, as they were only approved for use in China after 2009.

[Read More]